ArticleBMC psychiatry2026
The role of plasma oxytocin in early-onset schizophrenia: implications for disease severity and early intervention.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionEarly-onset schizophrenia (EOS) is a severe psychiatric disorder with poor long-term outcomes. It offers a unique opportunity to examine the neurobiological mechanisms of schizophrenia without the confounding effects of adult environmental factors. Oxytocin (OXT), a neuropeptide involved in social and emotional regulation, has been linked to several psychiatric conditions, including schizophrenia. This study investigated associations between plasma OXT levels, disease severity, personality traits, and childhood trauma in EOS.
methodsParticipants were 118 patients with EOS and 76 healthy controls (HC). Plasma OXT levels were measured, symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS), personality traits were evaluated with the Chinese Adolescent Personality Five-Factor Inventory, and childhood trauma was measured using the Childhood Trauma Questionnaire-Short Form. Analyses included independent-samples t tests, chi-square tests, binary logistic regression, receiver operating characteristic (ROC) curve analysis, and correlation analysis using SPSS and R.
resultsEOS patients had significantly lower plasma OXT levels than HC (P < 0.001). Sex, extraversion, OXT levels, and emotional abuse predicted EOS, explaining 55.4% of the variance. OXT levels showed moderate diagnostic utility (Area under the curve, AUC = 0.776) with an optimal cutoff of 183.428 pg/mL. In patients with milder symptoms (PANSS < 65), OXT levels positively correlated with symptom severity (r = 0.482, P = 0.020); no correlation was found in severe cases.
conclusionsAltered OXT levels may be associated with EOS pathophysiology, particularly in early stages. Plasma OXT levels may have potential as biomarkers for early diagnosis and intervention, pending validation in longitudinal studies, supporting future research on personalized treatment strategies.
Indexed as
Identifiers
42850602What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.